Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:22 Issue:1 Number:1 ISSN#:2564-2537
Author Verified
ACE Report #13444
Ace Report Cover Foot & Ankle

Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis

How to Cite

OrthoEvidence. Botulinum Toxin A Improves Foot Function At 24 Weeks vs Ropivacaine for Plantar Fasciitis. ACE Report. 2021;22(1):1. Available from: https://myorthoevidence.com/AceReport/Report/13444

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of Botulinum Toxin A, Corticosteroid, and Anesthetic Injection for Plantar Fasciitis

Foot Ankle Int. 2021 Mar;42(3): 305-313.

Contributing Authors: J Elizondo-Rodríguez M Simental-Mendía V Peña-Martínez F Vilchez-Cavazos Y Tamez-Mata C Acosta-Olivo

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here


Seventy-one patients with ≥2 months of persisting heel pain at the origin of the plantar fascia unresponsive to conventional therapies were randomized to receive a single injection of ropivacaine (5 mL; n=23), an intra-lesional injection of betamethasone sodium phosphate (1 mL; n=25), or an intralesional injection of 200 U of botulinum toxin A (BoNT-A; n=23) injection, administered using ultrasoun...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

For Reprints and Permissions, click here

Please Login or Join to leave comments.